These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 20666850)

  • 1. Fell-Muir Lecture: Metalloproteinases: from demolition squad to master regulators.
    Murphy G
    Int J Exp Pathol; 2010 Aug; 91(4):303-13. PubMed ID: 20666850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of metzincin family members with small-molecule inhibitors: progress toward a multifarious challenge.
    Georgiadis D; Yiotakis A
    Bioorg Med Chem; 2008 Oct; 16(19):8781-94. PubMed ID: 18790648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular regulation of metalloproteinases.
    Yamamoto K; Murphy G; Troeberg L
    Matrix Biol; 2015; 44-46():255-63. PubMed ID: 25701651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue inhibitors of metalloproteinases.
    Murphy G
    Genome Biol; 2011 Nov; 12(11):233. PubMed ID: 22078297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intra- and interdomain flexibility in matrix metalloproteinases: functional aspects and drug design.
    Bertini I; Fragai M; Luchinat C
    Curr Pharm Des; 2009; 15(31):3592-605. PubMed ID: 19925414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation matrix metalloproteinase inhibitors - Novel strategies bring new prospects.
    Levin M; Udi Y; Solomonov I; Sagi I
    Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):1927-1939. PubMed ID: 28636874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloproteinases: their role in arthritis and potential as therapeutic targets.
    Clark IM; Parker AE
    Expert Opin Ther Targets; 2003 Feb; 7(1):19-34. PubMed ID: 12556200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive site mutations in tissue inhibitor of metalloproteinase-3 disrupt inhibition of matrix metalloproteinases but not tumor necrosis factor-alpha-converting enzyme.
    Wei S; Kashiwagi M; Kota S; Xie Z; Nagase H; Brew K
    J Biol Chem; 2005 Sep; 280(38):32877-82. PubMed ID: 16079149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elucidating the function of non catalytic domains of collagenases and aggrecanases.
    Nagase H; Fushimi K
    Connect Tissue Res; 2008; 49(3):169-74. PubMed ID: 18661336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress in matrix metalloproteinase research.
    Murphy G; Nagase H
    Mol Aspects Med; 2008 Oct; 29(5):290-308. PubMed ID: 18619669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase target family landscape: a chemometrical approach to ligand selectivity based on protein binding site analysis.
    Pirard B; Matter H
    J Med Chem; 2006 Jan; 49(1):51-69. PubMed ID: 16392792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
    Binder MJ; Ward AC
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic Activity Matrix Analysis (PrAMA) for simultaneous determination of multiple protease activities.
    Miller MA; Barkal L; Jeng K; Herrlich A; Moss M; Griffith LG; Lauffenburger DA
    Integr Biol (Camb); 2011 Apr; 3(4):422-38. PubMed ID: 21180771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis of matrix metalloproteinase function.
    Bode W
    Biochem Soc Symp; 2003; (70):1-14. PubMed ID: 14587278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases: fold and function of their catalytic domains.
    Tallant C; Marrero A; Gomis-Rüth FX
    Biochim Biophys Acta; 2010 Jan; 1803(1):20-8. PubMed ID: 19374923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The design, structure, and therapeutic application of matrix metalloproteinase inhibitors.
    Skiles JW; Gonnella NC; Jeng AY
    Curr Med Chem; 2001 Mar; 8(4):425-74. PubMed ID: 11172697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
    Apte SS; Parks WC
    Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies against metzincin targets.
    Santamaria S; de Groot R
    Br J Pharmacol; 2019 Jan; 176(1):52-66. PubMed ID: 29488211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.